Benzinga | Nov 3, 2021 09:16AM EDT

Agios Pharmaceuticals Q3 EPS $(1.56) Beats $(1.59) Estimate

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.56) per share which beat the analyst consensus estimate of $(1.59) by 1.89 percent. This is a 9.09 percent decrease over losses of $(1.43) per share from the same period last year.